Mrv1652306231722472D 17 15 0 0 1 0 999 V2000 -2.9678 0.1904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2533 -0.2221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.5389 0.1904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8244 -0.2221 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.1099 0.1904 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.6046 -0.2221 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.3190 0.1904 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.0335 -0.2221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7480 0.1904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3190 1.0154 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.6046 -1.0471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.1099 1.0154 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.8244 -1.0471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7533 0.7145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.3408 -0.0000 0.0000 Sb 0 0 0 0 0 0 0 0 0 0 0 0 5.7533 -0.7145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.5158 -0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 7 10 1 6 0 0 0 6 11 1 1 0 0 0 5 12 1 1 0 0 0 4 13 1 1 0 0 0 14 15 1 0 0 0 0 15 16 2 0 0 0 0 15 17 2 0 0 0 0 M END > DB13732 > drugbank > O[Sb](=O)=O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO > InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1 > XOGYVDXPYVPAAQ-SESJOKTNSA-M > C7H18NO8Sb > 365.98 > 365.00705 > 6 > 35 > 19.52428832650866 > 1 > 6 > 0 > 0 > (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; oxostibinic acid > -2.36 > -3.4043202516666664 > 0.09 > 0 > 0 > 1 > 13.524639684996114 > 12.649771460982581 > 9.113333213275927 > 113.18 > 44.835699999999996 > 6 > 0 > 2.40e+02 g/l > N-methyl-D(-)-glucamine; oxostibinic acid > 0 > DB13732 > experimental; investigational > Meglumine antimoniate > Antimoniato de meglumina; Glucantim; Glucantime; Meglumine antimonate; Meglumine antimoniate $$$$